Fusion Pharmaceuticals Inc. Total Assets
Fusion Pharmaceuticals Inc. had Total Assets of $323.81 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2024-05-07
- 2024-03-31: Assets $323.81M.
- 2023-12-31: Assets $285.84M.
- 2023-09-30: Assets $253.38M.
- 2023-06-30: Assets $268.29M.
| Period end | Assets |
|---|---|
| 2024-03-31 | $323.81M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $285.84M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $253.38M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $268.29M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $266.55M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $219.06M 10-K · filed 2024-03-20 |
| 2022-09-30 | $238.49M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $228.13M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $235.96M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $252.27M 10-K · filed 2023-03-16 |
| 2021-09-30 | $268.30M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $282.16M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $297.31M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $310.68M 10-K · filed 2022-03-17 |
| 2020-09-30 | $312.06M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $323.11M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $69.40M 10-K · filed 2021-03-25 |